tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
PremiumCompany AnnouncementsChemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
1M ago
Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support
Premium
Ratings
Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support
2M ago
Chemomab Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Chemomab Therapeutics Reports Q2 2025 Financial Results
2M ago
Chemomab Therapeutics announces data from Phase 2 SPRING trial of nebokitug
PremiumThe FlyChemomab Therapeutics announces data from Phase 2 SPRING trial of nebokitug
3M ago
Chemomab obtained feedback from two recent FDA meetings on nebokitug
Premium
The Fly
Chemomab obtained feedback from two recent FDA meetings on nebokitug
4M ago
Chemomab announces nebokitug awarded new patent protection in China, Russia
Premium
The Fly
Chemomab announces nebokitug awarded new patent protection in China, Russia
4M ago
Chemomab Therapeutics Advances Nebokitug Towards Phase 3 After Positive Trial Results
PremiumCompany AnnouncementsChemomab Therapeutics Advances Nebokitug Towards Phase 3 After Positive Trial Results
5M ago
Chemomab Therapeutics reports Q1 EPS $0.007 vs $0.014 last year
Premium
The Fly
Chemomab Therapeutics reports Q1 EPS $0.007 vs $0.014 last year
5M ago
Chemomab Therapeutics: Promising Phase 2 Data and Attractive Entry Point Justify Buy Rating
Premium
Ratings
Chemomab Therapeutics: Promising Phase 2 Data and Attractive Entry Point Justify Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100